{"nctId":"NCT01039792","briefTitle":"Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism","startDateStruct":{"date":"2010-01"},"conditions":["Autistic Disorder"],"count":57,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Placebo"]},{"label":"Active","type":"EXPERIMENTAL","interventionNames":["Drug: Methyl B12"]}],"interventions":[{"name":"Methyl B12","otherNames":["Vitamin B12","methylcobalamin"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Diagnosis of DSM IV defined autism and meets cut off on Autism Diagnostic Inventory-Revised (ADI-R) and/or the Autism Diagnostic Observation Scale (ADOS)\n* Age 3 through 7 years\n* IQ of 50 or above\n* Parental agreement to continue present dietary, behavioral or psychotropic drug treatment but not change treatment during 8 week intervention\n* Willingness to have blood drawn, without the use of a sedative prescription from the study doctor\n\nExclusion Criteria:\n\n* Bleeding disorder\n* Cancer\n* Seizure disorder\n* Fragile X or other known genetic cause of autism\n* Perinatal brain injury (i.e.: cerebral palsy)\n* Other serious medical illnesses\n* Current use of any B12 supplement","healthyVolunteers":false,"sex":"ALL","minimumAge":"3 Years","maximumAge":"7 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clinical Global Impression-Improvement (CGI-I)","description":"PI assesses subject's change using the CGI-I measure. This is a 7-point Likert scale that assesses improvement of the patient's condition. Scores range from the worst score of 7 (Very much worse) to the best score of 1 (Very much improved). Lower scores are better on this scale, and indicate greater improvement.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":"0.8"},{"groupId":"OG001","value":"2.4","spread":"0.8"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["increased hyperactivity","mouthing","cold","trouble sleeping","fever"]}}}